Inspire Medical Systems, Inc. (INSP)
NYSE · Healthcare
Inspire Medical Systems, Inc. EBITDA 2016–2025
Inspire Medical Systems, Inc. annual/quarterly ebitda history and growth rate from 2016 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Inspire Medical Systems, Inc. ebitda for the quarter ending March 31, 2026 was 4.0 M, a 156.06% increase year-over-year.
- Inspire Medical Systems, Inc. ebitda for the twelve months ending March 31, 2026 was 19.0 M, a 538.01% decrease year-over-year.
- Inspire Medical Systems, Inc. annual ebitda for 2025 was 64.9 M, a 52.26% increase from 2024.
- Inspire Medical Systems, Inc. annual ebitda for 2024 was 42.6 M, a 213.92% decrease from 2023.
- Inspire Medical Systems, Inc. annual ebitda for 2023 was -37.4 M, a 18.17% decrease from 2022.
- Inspire Medical Systems, Inc. annual ebitda for 2022 was -45.7 M.
EBITDA
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Inspire Medical Systems, Inc. EBITDA — FAQ
Inspire Medical Systems, Inc. (INSP) ebitda over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see INSP's ebitda history?
The chart and table above show Inspire Medical Systems, Inc.'s ebitda by year and by quarter, including the growth rate.